Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hong J. Kan"'
Autor:
Hong J. Kan, Kirill Dyagilev, Peter Schulam, Suchi Saria, Hadi Kharrazi, David Bodycombe, Charles T. Molta, Jeffrey R. Curtis
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-12 (2018)
Abstract Background This study estimated the extent and predictors of primary nonadherence (i.e., prescriptions made by physicians but not initiated by patients) to methotrexate and to biologics or tofacitinib in rheumatoid arthritis (RA) patients wh
Externí odkaz:
https://doaj.org/article/a956dbfba0914a4ea36cdc2637bd19ff
Autor:
Xia Wang, G Caleb Alexander, Irene B Murimi-Worstell, Dora H Lin, Henk Nab, Hong J Kan, Oluwadamilola Onasanya, Jonothan C Tierce, Barnabas Desta, Edward R Hammond
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Objective At least half of patients with systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease or long-term therapeutic steroid use. This study synthesised evidence on the association between organ damage and
Externí odkaz:
https://doaj.org/article/cd6e65aff9d5440492302d2a15a54e3b
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0213258 (2019)
BACKGROUND:Payers and providers still primarily use ordinary least squares (OLS) to estimate expected economic and clinical outcomes for risk adjustment purposes. Penalized linear regression represents a practical and incremental step forward that pr
Externí odkaz:
https://doaj.org/article/028ff42c5bcf4dfcbbfdac018abbbba4
Autor:
Stephen R. Wisniewski, Zhenchao Guo, Andrei Pikalov, Quynh Van Tran, Chi Chang Chen, Hong J. Kan, Edward Kim, Berit X. Carlson
Publikováno v:
Pharmacoepidemiology and Drug Safety. 18:965-972
Objective This study quantified the overall merit of adjunctive aripiprazole in major depressive disorder (MDD). Methods Global benefit–risk (GBR) analysis quantified the benefit and risk differences between adjunctive aripiprazole and antidepressa
Autor:
Richard Whitehead, Zhenchao Guo, John A. Bates, John M. Kane, Edward Kim, Hong J. Kan, Andrei Pikalov
Publikováno v:
Applied Health Economics and Health Policy. 7:109-119
Background: Since their introduction, second-generation antipsychotics (SGAs) have become the drugs of choice for the treatment of schizophrenia. However, recent findings have questioned the benefits of SGAs over first-generation antipsychotics (FGAs
Autor:
Cristina, Drenkard, Gaobin, Bao, Greg, Dennis, Hong J, Kan, Priti M, Jhingran, Charles T, Molta, S Sam, Lim
Publikováno v:
Arthritis careresearch. 66(6)
To examine the burden of systemic lupus erythematosus (SLE) on work loss, unemployment, and work productivity impairment in an SLE cohort from the southeastern US.We examined 689 SLE patients ages 18-64 years from the Georgians Organized Against Lupu